Skip to Content
You are currently on the new version of our website. Access the old version .

Drugs and Drug Candidates, Volume 5, Issue 3

2026 September - 15 articles

Cover Story: Geraniol, a naturally occurring monoterpene found in a wide range of aromatic plants, has attracted growing interest due to its diverse pharmacological properties. However, its potential to act on multiple molecular targets remains insufficiently explored. In this study, network pharmacology and ADMET modeling were integrated to investigate the multitarget therapeutic potential of geraniol. Through analysis, we identified key molecular targets and biological pathways potentially underlying its pharmacological effects, highlighting interactions with mechanisms associated with inflammation, oxidative stress, and other relevant pathological processes. These findings provide a systems-level perspective on the biological activity of geraniol and support its potential as a promising multitarget bioactive compound for future research. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (15)

  • Article
  • Open Access
333 Views
31 Pages

Background/Objectives: The therapeutic durability of β-lactams is increasingly threatened by penicillin-binding proteins (PBPs) that retain cell-wall transpeptidase activity under antibiotic pressure. This study computationally evaluated 221 Dan...

(This article belongs to the Section In Silico Approaches in Drug Discovery)
  • Review
  • Open Access
471 Views
26 Pages

Proteolytic processing of viral polyproteins by virally encoded proteases is essential for the replication of many RNA viruses, including retroviruses and coronaviruses, which are two of the best characterized model systems discussed in this review....

(This article belongs to the Special Issue Therapeutic Protease and Peptidase Inhibitors)
  • Article
  • Open Access
371 Views
17 Pages

Integrative Experimental and Molecular Docking Analyses Reveal Phenanthroline Derivatives as Inhibitors of Cyanide-Resistant Respiration in Candida albicans

  • Erick Sierra Campos,
  • Mónica Andrea Valdez Solana,
  • Karla Valeria Ibarra Mena,
  • Estela Ruiz Baca and ,
  • Claudia Avitia Domínguez and
  • Alfredo Téllez Valencia
  • + 1 author+ 0 author

Background: Candida albicans can adapt to inhibition of the classical mitochondrial respiratory chain by activating an alternative oxidase (AOX)-dependent pathway, whereas Candida glabrata lacks detectable AOX-mediated respiration under the condition...

(This article belongs to the Section In Silico Approaches in Drug Discovery)
  • Article
  • Open Access
597 Views
26 Pages

Deep Learning-Based Molecular Generation for Lung Cancer Therapeutics

  • Mohavia Ben Amid Sinon and
  • Uche A. K. Chude-Okonkwo

Background: The leading cause of cancer-related deaths globally is lung cancer, and the P2X7 receptor (P2X7R) is a promising therapeutic target due to its role in the disease progression. Methods: A deep learning-based molecular generation framework...

(This article belongs to the Section In Silico Approaches in Drug Discovery)
  • Review
  • Open Access
2 Citations
807 Views
34 Pages

The global emergence of multidrug-resistant fungal pathogens, including Candida auris, Candida albicans, Aspergillus fumigatus, Cryptococcus neoformans, and Pneumocystis jirovecii, poses a growing threat to public health, particularly among immunocom...

(This article belongs to the Special Issue Microbes and Medicines)
  • Article
  • Open Access
1,359 Views
18 Pages

Exploring the In Vitro Effect of Psilocybin on the Composition and Metabolic Activity of Gut Microbiota in Individuals with Severe Anxiety

  • Mateus Kawata Salgaço,
  • David de Paulo Farias,
  • Mariela Zucolo de Souza,
  • Adilson Sartoratto and ,
  • Flavia Bottino,
  • Hernane da Silva Barud,
  • Fellipe Lopes de Oliveira,
  • Alexandra Ivo de Medeiros,
  • Breno Vilas Boas Raimundo and
  • Katia Sivieri
  • + 9 authors+ 4 authors

Background/Objectives: This study investigated the effects of a single dose of psilocybin-containing Psilocybe cubensis extract on gut microbiota composition, microbial metabolism, and intestinal immune-related responses. Methods: A single dose of P....

(This article belongs to the Section Preclinical Research)
  • Conference Report
  • Open Access
1,006 Views
100 Pages

33rd GP2A Annual Medicinal Chemistry Conference, XIVth Paul Ehrlich MedChem Euro-PhD Network Meeting & COST Action One Health Drugs Against Parasitic Vector Borne Diseases in Europe and Beyond (OneHealthdrugs)

  • Florence O. McCarthy,
  • Jean-Jacques Hélesbeux,
  • Marc-Antoine Bazin,
  • Tatiana Bernoussi and ,
  • Justine Bonnet,
  • Cédric Logé,
  • Isabelle Ourliac-Garnier,
  • Jean-Michel Robert,
  • Mathieu Scaviner and
  • Pascal Marchand
  • + 10 authors+ 5 authors

The 33rd Annual Conference of the Group for the Promotion of Pharmaceutical Chemistry in Academia (GP2A), held in Nantes from 11 to 13 June 2025, marked a significant expansion of the organization’s scope and collaborative efforts. Building on...

  • Opinion
  • Open Access
1,029 Views
13 Pages

Therapeutic Appropriateness of Paracetamol and NSAIDs in Management of Fever and Pain in Pediatric Patients with Comorbidities: An Expert Opinion

  • Claudia Colomba,
  • Diego Maria Michele Fornasari,
  • Michele Miraglia del Giudice,
  • Andrea Pasini and
  • Claudio Romano

Background. Paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs) are widely used treatments for mild to moderate pain and fever in pediatric patients. Notwithstanding, greater caution and awareness of their distinct safety profiles is warra...

(This article belongs to the Section Marketed Drugs)
  • Review
  • Open Access
747 Views
44 Pages

Natural Antihypertensive Drug Leads from Northeast India’s Biodiversity Hotspots: Molecular Targets, Signaling Pathways, and Safety Profiles: A Review

  • Pranab Borah,
  • Saddam Hussain,
  • Arlin Sen,
  • Raju Bharalee and ,
  • Mayuri Chabukdhara,
  • Hrishikesh Upadhyaya,
  • Dhrubajyoti Gogoi and
  • Akalesh Kumar Verma
  • + 3 authors+ 0 author

Hypertension is a major global health concern affecting over one billion people worldwide and is a leading risk factor for cardiovascular diseases, stroke, and kidney failure. Plant-derived bioactive compounds provide promising natural strategies for...

(This article belongs to the Section Drug Candidates from Natural Sources)
  • Systematic Review
  • Open Access
978 Views
18 Pages

Backgrounds: Astragalus membranaceus (AM), a traditional Chinese medicinal herb, has garnered interest for its potential in anticancer therapy. Preclinical evidence suggests that AM inhibits tumor growth and could mitigate the adverse effects as...

(This article belongs to the Section Drug Candidates from Natural Sources)
  • Article
  • Open Access
804 Views
32 Pages

Integrative Network Pharmacology and ADMET Modeling Reveal the Multitarget Therapeutic Potential of Geraniol

  • Mateus Henrique de Almeida da Costa,
  • Lívia Alves Filgueiras and
  • Anderson Nogueira Mendes

Background: Geraniol is an acyclic monoterpene widely distributed in the essential oils of aromatic species such as Cymbopogon citratus, Pelargonium graveolens, and Rosa damascena, It is known for its antioxidant, anti-inflammatory, neuroprotective,...

(This article belongs to the Section In Silico Approaches in Drug Discovery)
  • Review
  • Open Access
1 Citations
1,533 Views
12 Pages

Carbapenem-resistant Acinetobacter baumannii (CRAB) is classified by the World Health Organization among the critical-priority pathogens, reflecting high mortality, near-ubiquitous nosocomial spread, and a depleted therapeutic pipeline. No antibiotic...

(This article belongs to the Special Issue Microbes and Medicines)
  • Review
  • Open Access
2,474 Views
53 Pages

Drug recall is a critical regulatory mechanism implemented to protect public health by removing defective, unsafe, or non-compliant pharmaceutical products from the market. Despite stringent regulatory approval processes, issues related to manufactur...

(This article belongs to the Section Marketed Drugs)
  • Review
  • Open Access
3 Citations
1,483 Views
24 Pages

Plant Secondary Metabolites as Next-Generation Antibiofilm and Antimicrobial Agents: Mechanisms, Synergistic Effects, and Clinical Translation

  • Saravanakumar Parameswaran,
  • Satheesh Babu Natarajan,
  • Nivetha Shanmugam and
  • Anandarajagopal Kalusalingam

One of the most pressing challenges facing healthcare today is the rise of biofilm infections and antibiotic-resistant bacteria, which demand entirely new therapeutic strategies beyond conventional antibiotic reliance. A biofilm is a structured commu...

(This article belongs to the Section Drug Candidates from Natural Sources)
  • Review
  • Open Access
5 Citations
1,698 Views
18 Pages

Background: Microbiome-oriented therapies, including fecal microbiota transplantation (FMT), phage therapy, and live biotherapeutic products (LBPs), represent a promising direction in modern biomedicine for addressing antimicrobial resistance (AMR),...

(This article belongs to the Special Issue Microbes and Medicines)
XFacebookLinkedIn
Drugs Drug Candidates - ISSN 2813-2998